issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard: SIX Swiss Exchange language: English ...
London (ots/PRNewswire) - EvaluatePharma Ltd, a leading source for life science sector analysis and the first to supply reliable consensus forecasts of global drug sales, revealed today that Novartis is expected to take the top spot amongst the world's pharmaceuticals manufacturers, in terms of prescription (Rx) drug sales, starting in 2014 and remains at the top ...
Shire Pharmaceuticals Group Plc
Philadelphia (ots/PRNewswire) - - Company Plans to Conduct Additional Analyses of These Preliminary Data Shire plc [http://www.shire.com/shireplc/en/home ] , the global specialty biopharmaceutical company, today announced positive top-line results from a Phase 2 study to evaluate the safety and efficacy of ...
http://resources.euroadhoc.com/us/uwOkosUu issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: free trade: ...
Calgary, Alberta (ots/PRNewswire) - This Novel Epigenetic Mechanism Defines an Entirely New Class of Therapeutic TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix" or the "Company") today announces the "Mechanism of Action" (MoA) by which RVX-208 increases apolipoprotein A-I (ApoA-I) production. Our data shows RVX-208 to be an inhibitor of the Bromodomain and ...
Frankfurt And Hatfield, England (ots/PRNewswire) - ? The German Federal Joint Committee (G-BA), the supreme decision-making body of the self-governing medical system in Germany, announced that it considers the use of Halaven(R) (eribulin) to have additional benefit versus comparative treatments, defined by the G-BA ...
http://resources.euroadhoc.com/us/lBLJuRAt issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Calgary, Alberta (ots/PRNewswire) - Dr. Stephen J. Nicholls joins as guest speaker TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix" or the "Company") is pleased to announce for the first time the "Mechanism of Action" (MoA) by which RVX-208 increases apolipoprotein A-I (ApoA-I) production. Please join us via Conference Call & Webcast on Monday, April 23, 2012, ...
Barcelona, Spain (ots/PRNewswire) - - Retrospective sub-analyses from ADVANCE, ILLUMINATE and REALIZE Phase 3 studies will be presented at European Association for the Study of the Liver (EASL) 2012 - Janssen Pharmaceutica NV (Janssen) will present new data for INCIVO (telaprevir) from Phase 3 retrospective ...
Hatfield, England (ots/PRNewswire) - Reimbursement granted for Zebinix(R) as adjunctive therapy for adults with partial-onset seizures Eisai Europe Limited announces the launch of Zebinix(R) (eslicarbazepine acetate) in France. Upon launch, this novel epilepsy drug will receive full reimbursements from the French health authorities. Once-daily eslicarbazepine acetate is indicated as an adjunctive (add-on) therapy for ...
Hatfield, England (ots/PRNewswire) - New EMEA Dubai Office Part of Expansion Plans into Middle East and Parts of Africa PRESS RELEASE NOT INTENDED FOR DUBAI MEDIA Japanese company Eisai is expanding its geographical and patient reach by opening a new regional representative office in Dubai today. The Eisai EMEA (Europe, Middle East and Africa) Dubai branch office, located in Dubai Healthcare City (DHCC), marks the ...
Monheim, Germany (ots/PRNewswire) - Four WebConferences from 7th International CVBD World Forum attract more than 3,000 viewers from around the world to hear case studies from leading international experts Bayer Animal Health today announced that the recent educational WebConfererences following the Seventh Canine Vector-Borne Disease (CVBD) World Forum were watched by ...
Hatfield, England (ots/PRNewswire) - Child-friendly formulation now available for the treatment of Lennox-Gastaut syndrome Eisai Europe Limited today announced the launch of Inovelon(R) (rufinamide) oral suspension in Denmark for adjunctive (add-on) treatment of seizures associated with Lennox-Gastaut syndrome (LGS), in children four years and older. Many patients who receive the orphan drug rufinamide are children, ...
Shire Pharmaceuticals Group Plc
Dublin (ots/PRNewswire) - Shire plc , the global specialty biopharmaceutical company, will announce first quarter 2012 earnings on Thursday April 26, 2012. Results press release will be issued at: 12:00 BST / 07:00 EDT Investor conference call time: 14:00 BST / 09:00 EDT Live conference call for investors: Angus Russell, Chief Executive Officer and Graham Hetherington, ...
Shire Pharmaceuticals Group Plc
Dublin (ots/PRNewswire) - Shire plc , the global specialty biopharmaceutical company, today announced that it has signed an agreement to acquire substantially all the assets of Pervasis Therapeutics. Shire will provide Pervasis with an upfront payment, plus potential post-closing milestone payments that are dependent on Shire's achievement of certain clinical ...
Birmingham, England (ots/PRNewswire) - Not Intended For UK Media New collar from Bayer Animal Health offers dogs and cats an unparalleled protection period of up to eight months from ticks and fleas in a single treatment Bayer Animal Health today launched Seresto (known as Foresto in some European markets*), the latest in a long line of innovative anti-parasite products from one of the world's leading animal health ...
London (ots/PRNewswire) - Nutricia Advanced Medical Nutrition, the specialised healthcare unit of Danone, will serve as a partner in the implementation stage of the Active and Healthy Ageing (AHA) project, the EU-led initiative intended to help older Europeans enjoy a more active and healthy life. The announcement ...
Tokyo (ots/PRNewswire) - ? Hoya Corporation's Vision Care Division, a key player in the global market for ophthalmic lenses, today announced the acquisition of Optotal Hoya S.A., its exclusive partner in Brazil. Optotal operates the largest prescription lens (Rx) laboratory and one of the largest wholesale distribution networks in the ophthalmic lens market in Brazil. HOYA's cooperation with Optotal started in 1992 with a ...
Shire Pharmaceuticals Group Plc
Philadelphia, Pennsylvania (ots/PRNewswire) - Shire plc , the global specialty biopharmaceutical company, today announced top-line results of the PREVENT2 trial, a phase 3 investigational study of once-daily SPD476, MMX(R) mesalamine in patients with a history of diverticulitis.[1] The study, conducted in 10 countries worldwide including the United States, did not meet the primary endpoint in reducing the rate of ...
Monheim, Germany (ots/PRNewswire) - As part of its ongoing commitment to the scientific community, Bayer Animal Health today marked their seventh year of support for the CVBD World Forum (CVBD7) in Berlin, Germany; and this year's meeting has again proven to be a landmark in the understanding of CVBDs. CVBDs present ...
http://resources.euroadhoc.com/us/JrNcWOXN issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: CH0012815459 indexes: SPI, SPIEX stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard: SIX Swiss ...
Astellas Pharma Europe Limited
Staines, England (ots/PRNewswire) - ASTELLAS PHARMA EUROPE Ltd., the European subsidiary of Tokyo - based Astellas Pharma Inc. today announced the submission of a Market Authorisation Application for EC905 in the Netherlands. This application for approval is the first step of the European-wide mutual recognition ...
http://resources.euroadhoc.com/us/CR4ucQv9 issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
The International Osteoporosis Foundation (IOF)
Bordeaux, France (ots) - Today, at the European Congress on Osteoporosis & Osteoarthritis, healthcare experts and national patient society advocates from around the world attended a special session devoted to the problem of secondary fractures and their prevention. At the heart of the problem is the fact that a ...
Geneva (ots/PRNewswire) - Results Reconfirm Test's Cost-Effectiveness, Emphasise Important Role in Guiding Treatment Decisions Genomic Health, Inc. today announced results of three new Oncotype DX(R) studies including data demonstrating the test's cost-effectiveness within the German and Hungarian healthcare ...
Minneapolis And Geneva (ots/PRNewswire) - Milestone comes 25 years after the first DBS implant for Tremor carried out in Grenoble, France Medtronic, Inc. today announced that a patient from Kempenhaeghe-Heeze (The Netherlands) is the first patient to be enrolled into the MORE (MedtrOnic Registry for Epilepsy) ...
Shire Pharmaceuticals Group Plc
Dublin (ots/PRNewswire) - ? Shire plc , the global specialty biopharmaceutical company, announces that it has signed an agreement to acquire FerroKin BioSciences, Inc., for an upfront payment of $100 million, payable in cash at closing, plus potential post-closing milestone payments of up to $225 million, depending upon the achievement of certain clinical development, ...
Bangalore, India, London, And New York (ots/PRNewswire) - An Integrated Platform and Services Solution to Streamline Global Digital Engagement Infosys Ltd , today, announced its partnership with GlaxoSmithKline (GSK) to optimize digital channels across its global consumer healthcare and pharmaceuticals business ...
http://resources.euroadhoc.com/us/Rd8E7zsy issuer: LifeWatch AG Rundbuckstrasse 6 CH-8212 Neuhausen am Rheinfall phone: +41 52 632 00 50 FAX: +41 52 632 00 51 mail: users@lifewatch.com WWW: www.lifewatch.com sector: Healthcare Providers ISIN: ...
Bern, Switzerland (ots) - - - Quality of Life (QoL) is strongly diminished in RVVC patients - Current available treatment fails in two thirds of patients - High medical need demands novel effective treatment options Pevion Biotech AG today announced results from a large, international survey on the Quality of Life ...